Pharmacokinetics | Acumen Pharmaceuticals

2024 AAIC Poster

August 14, 2024/in 2024 2024, AAIC, INTERCEPT-AD, Pharmacokinetics, Poster, sabirnetug, TwentyTwentyFour /by Robyn Moxon

2024 AAIC Poster:

INTERCEPT-AD: Development and Qualification of a Highly Sensitive Immunoassay Detecting Total Sabirnetug (ACU193) in Human CSF

2023 CTAD Poster

May 31, 2023/in 2023 2023, CTAD, INTERCEPT-AD, Pharmacokinetics, Poster, TwentyTwentyThree /by Robyn Moxon

2023 CTAD Poster:

INTERCEPT-AD: ACU193 CSF pharmacokinetics in early Alzheimer’s disease.